Combinatorial Chemistry & High Throughput Screening 2010-08-01

Electrochemical behavior of triflusal, aspirin and their metabolites at glassy carbon and boron doped diamond electrodes.

Teodor Adrian Enache, Orlando Fatibello-Filho, Ana Maria Oliveira-Brett

Index: Comb. Chem. High Throughput Screen 13(7) , 569-77, (2010)

Full Text: HTML

Abstract

The electrochemical behavior of triflusal (TRF) and aspirin (ASA), before and after hydrolysis in water and in alkaline medium using two different electrode surfaces, glassy carbon and boron doped diamond, was study by differential pulse voltammetry over a wide pH range. The hydrolysis products are 2-(hydroxyl)-4-(trifluoromethyl)-benzoic acid (HTB) for triflusal and salicylic acid (SA) for aspirin, which in vivo represent their main metabolites. The hydrolysis processes were also followed by spectrophotometry. The UV results showed complete hydrolysis after one hour for TRF and after two hours for ASA in alkaline solution. The glassy carbon electrode enables only indirect determination of TRF and ASA through the electrochemical detection of their hydrolysis products HTB and SA, respectively. The oxidation processes of HTB and SA are pH dependent and involve different numbers of electrons and protons. Moreover, the difference between the oxidation peak potential of SA and HTB was equal to 100 mV in the studied pH range from 1 to 8 due to the CF3 of the aromatic ring of HTB molecule. Due to its wider oxidation potential range, the boron doped diamond electrode was used to study the direct oxidation of TRF and ASA, as well as of their respective metabolites HTB and SA.


Related Compounds

Related Articles:

Long-term follow-up of atrial fibrillation patients in the NASPEAF study. Prospective evaluation of different antiplatelet treatments.

2009-09-01

[Rev. Esp. Cardiol. 62(9) , 992-1000, (2009)]

A phase I study to characterize the multiple-dose pharmacokinetics, pharmacodynamics and safety of new enteric-coated triflusal formulations in healthy male volunteers.

2011-12-01

[Expert Opin. Drug Metab. Toxicol. 7(12) , 1471-9, (2011)]

Comparative bioavailability study of triflusal oral solution vs. triflusal capsules in healthy subjects. A single, randomized, two-way cross-over, open-label phase I study.

2010-01-01

[Arzneimittelforschung 60(1) , 36-41, (2010)]

Gastrointestinal safety of triflusal solution in healthy volunteers: a proof of concept endoscopic study.

2011-07-01

[Eur. J. Clin. Pharmacol. 67(7) , 663-9, (2011)]

Triflusal: an old drug in modern antiplatelet therapy. Review of its action, use, safety and effectiveness.

2009-01-01

[Hellenic J. Cardiol. 50(3) , 199-207, (2009)]

More Articles...